Zydus Wellness has released the audio recording of its investor call concerning the unaudited financial results for the quarter ended June 30, 2026. The recording is now available on the company’s official website, allowing stakeholders to review management’s commentary on the Q1FY27 performance. This disclosure ensures transparency and provides investors with direct access to the detailed discussion surrounding the quarterly figures.

The release of the recording was mandated under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Zydus Wellness Limited submitted the notice to both the BSE Limited and the National Stock Exchange of India Limited on August 4, 2026. The company secretary, Nandish P. Joshi, digitally signed the communication, confirming compliance with listing obligations.

Accessing the Recording

Investors can access the audio file directly through the link provided in the exchange filing. The recording covers the unaudited results for the quarter ended June 30, 2026.

Compliance and Disclosure

The notice was issued by the Listing Department of Zydus Wellness Limited, headquartered at Zydus Corporate Park in Ahmedabad. The filing confirms that the audio recording is hosted on the company’s investor relations page. This procedural step follows the standard timeline for post-result disclosures, ensuring that all market participants have equal access to the information presented during the conference call.

No specific financial metrics were detailed in this particular filing, as it serves solely as a pointer to the audio recording. Investors seeking quantitative data should refer to the separate financial results announcement or listen to the provided recording for a comprehensive breakdown of revenue, profit, and operational highlights for Q1FY27.

Zydus Wellness Limited shareholders approved the appointment of Mr. Apurva S. Diwanji as an Independent Director for a five-year term effective May 18, 2026, during its 32nd Annual General Meeting (AGM) held on August 4, 2026. The resolution passed with 87.48% support, though it faced significant opposition from institutional investors who voted against it at a rate of 53.20%. The meeting also saw the approval of a ₹1.20 per share dividend and the re-election of Dr. Sharvil P. Patel as a Non-Executive Director.

The appointment was formalized following a Board meeting on May 18, 2026, which recommended the resolution subject to shareholder approval. Mr. Diwanji’s term runs from May 18, 2026, to May 17, 2031, and he is not liable to retire by rotation. He will be entitled to receive sitting fees and commission as determined by the Board. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026.

AGM Voting Results

The AGM, conducted via Video Conference and Other Audio Visual Means (OAVM), recorded high participation from promoters but notable dissent from institutional blocks on governance matters. While financial resolutions received near-unanimous backing, board appointments drew mixed responses.

Mr. Diwanji brings over 32 years of experience in mergers and acquisitions, private equity, and joint ventures from his tenure at Desai & Diwanji. He holds a Master of Arts in Law from Downing College, Cambridge University, and a Bachelor of Arts in Economics from St. Xavier’s College, Mumbai. Currently, he serves as an Independent Director at Torrent Power Limited, Bajaj Life Insurance Limited, Bajaj General Insurance Limited, and TUV India Private Limited. Until May 12, 2026, he was an Independent Director at Zydus Lifesciences Limited.

What the Numbers Show

The voting pattern highlights a clear divergence between promoter and institutional shareholder preferences regarding board composition. While promoters voted unanimously in favor of Mr. Diwanji’s appointment, institutional investors opposed it by 53.20%. This contrasts sharply with the near-perfect consensus (>99.99%) on financial statements and dividend declarations. The data suggests that while operational and financial strategies are broadly aligned, governance structures remain a point of contention for institutional stakeholders, who also opposed Dr. Sharvil P. Patel’s re-election by 10.88%.